The present invention is related to a novel method for oxidizing or
splitting nucleic acids at specific points on a complementary nucleic
acid segment using a dinuclear copper-based compound of Formula I.
Additionally, the present invention is related to a novel treatment of
cancer, tumors, and cancer cells using a dinuclear copper-based compound
of formula I or a naked ligand of Formula II.
